Literature DB >> 22997993

Muscular strength and diameter as determinants of aerobic power and aerobic power response to exercise training in CAD patients.

Tom Thomaes1, Martine Thomis, Steven Onkelinx, Kaatje Goetschalckx, Robert Fagard, Véronique Cornelissen, Luc Vanhees.   

Abstract

OBJECTIVE: Low exercise capacity and skeletal muscle strength are important predictors of all-cause mortality in healthy as well as diseased individuals. Compared to sedentary subjects, CAD patients have a decreased oxygen uptake (peakVO2) and show accompanying increased muscle fatiguability. Despite the known importance of oxygen extraction by peripheral muscles on improving peakVO2 and of the relationship between muscle strength and aerobic capacity, only few studies in CAD patients include measurements of muscle strength before and after cardiac rehabilitation. This study therefore aimed to evaluate how much of the variance in baseline peakVO2 and its response to exercise training can be explained by muscular parameters.
METHODS: 260 CAD patients performed maximal incremental cycle ergometer testing and maximal knee muscle strength measurements. The rectus femoris diameter was measured using ultrasound. Zero order correlations were calculated and determinants of baseline and response in peakVO2 were analysed by multiple regression analysis.
RESULTS: PeakVO2 and muscle strength and diameter increased significantly after three months of cardiac rehabilitation (P < 0.0001). Zero order correlations showed significant correlations between muscular parameters and baseline peakVO2 (P < 0.0001). 63% of the total variance in baseline peakVO2 could be explained by seven parameters with knee extensor muscular endurance as the strongest predictor (P < 0.0001). 32% of the variation in relative increase in peakVO2 could be explained by 5 determinants of which the increase in muscular endurance was the strongest determinant (P < 0.0001).
CONCLUSIONS: Knee extensor muscular endurance and its response after training are the strongest muscular predictors in explaining peakVO2 and its response in CAD patients.

Entities:  

Mesh:

Year:  2012        PMID: 22997993     DOI: 10.1080/ac.67.4.2170680

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  3 in total

1.  PATHway I: design and rationale for the investigation of the feasibility, clinical effectiveness and cost-effectiveness of a technology-enabled cardiac rehabilitation platform.

Authors:  Jomme Claes; Roselien Buys; Catherine Woods; Andrew Briggs; Claudia Geue; Moira Aitken; Niall Moyna; Kieran Moran; Noel McCaffrey; Ioanna Chouvarda; Deirdre Walsh; Werner Budts; Dimitris Filos; Andreas Triantafyllidis; Nicos Maglaveras; Véronique A Cornelissen
Journal:  BMJ Open       Date:  2017-06-30       Impact factor: 2.692

2.  Feasibility, Acceptability, and Clinical Effectiveness of a Technology-Enabled Cardiac Rehabilitation Platform (Physical Activity Toward Health-I): Randomized Controlled Trial.

Authors:  Jomme Claes; Véronique Cornelissen; Clare McDermott; Niall Moyna; Nele Pattyn; Nils Cornelis; Anne Gallagher; Ciara McCormack; Helen Newton; Alexandra Gillain; Werner Budts; Kaatje Goetschalckx; Catherine Woods; Kieran Moran; Roselien Buys
Journal:  J Med Internet Res       Date:  2020-02-04       Impact factor: 5.428

3.  Home-Based Rehabilitation With Telemonitoring Guidance for Patients With Coronary Artery Disease (Short-Term Results of the TRiCH Study): Randomized Controlled Trial.

Authors:  Andrea Avila; Jomme Claes; Kaatje Goetschalckx; Roselien Buys; May Azzawi; Luc Vanhees; Véronique Cornelissen
Journal:  J Med Internet Res       Date:  2018-06-22       Impact factor: 5.428

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.